# Epigenetics, Vitamin C and Abnormal Hematopoiesis - Pilot Study

> **NCT02877277** · NA · COMPLETED · sponsor: **Rigshospitalet, Denmark** · enrollment: 20 (actual)

## Conditions studied

- Myelodysplastic Syndrome
- Acute Myeloid Leukemia

## Interventions

- **DIETARY_SUPPLEMENT:** Vitamin C
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT02877277
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08-08
- **Primary completion:** 2017-05-29
- **Final completion:** 2017-05-29
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2018-09-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02877277

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02877277, "Epigenetics, Vitamin C and Abnormal Hematopoiesis - Pilot Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02877277. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*